US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Onconetix Inc.

0.7822

-0.0310-3.81%

Post-market: 0.81500.0328+4.19%17:52 EDT

Volume:172.91K

Turnover:135.77K

Market Cap:3.09M

PE:-0.29

High:0.8439

Open:0.8186

Low:0.7670

Close:0.8132

52wk High:209.50

52wk Low:0.5868

Shares:3.95M

Float Shares:3.69M

Volume Ratio:0.10

T/O Rate:4.68%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.6880

EPS(LYR):-828.1488

ROE:-105.23%

ROA:-27.03%

PB:0.23

PE(LYR):0.00

Loading ...

Overview Company News Filings

Oncopeptides Accelerates CEE Expansion for Pepaxti via Exclusive Salus Distribution Deal

Onconetix Inc trading halted, news pending

BUZZ-U.S. STOCKS ON THE MOVE-T1 Energy, Home Depot, X-Energy

BRIEF-Onconetix, Inc. Announces 1-For-10 Reverse Stock Split

BRIEF-Realbotix Provides Update On Nasdaq Listing

Onconetix, Inc. Announces 1-for-10 Reverse Stock Split

THOMSON REUTERS

Realbotix says Nasdaq reverse takeover listing for unit expected to close by October 2026

Realbotix Corp - to Retain 75–90% Ownership of Realllc After Nasdaq Listing

THOMSON REUTERS

Onconetix (ONCO) Stock Surges Over 23% Overnight: Why Is It Moving?

Benzinga Earnings

Onconetix Q1 EPS $(6.71) Up From $(225.25) YoY, Sales $21.457K Down From $101.630K YoY

Benzinga Earnings

Onconetix unit Proteomedix launches Proclarix U.S. validation study with Labcorp

Onconetix Q1 net loss narrows 50.7% to $4.21 million

Oncopeptides showcases new Pepaxti data to bolster multiple myeloma positioning

Oncopeptides posts strong Q1 sales growth as Pepaxti momentum builds in Europe

Onconetix:Prospectus Relates to Offer & Sale From Time to Time by Keystone Capital Partners of up to 25 Mln Shares of Common Stock of Co

THOMSON REUTERS

Oncopeptides Targets Third-Line Multiple Myeloma Indication to Boost Pepaxti Growth

Oncopeptides Sets May 13 Webcast for Q1 2026 Results

Onconetix files to sell 25M shares of common stock for holders

Oncopeptides Marks Growth Phase as 2025 Annual Report Highlights Pepaxti Momentum

BRIEF-Onconetix Inc Andrew Oakley Resigns As Chairman Of Board

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/ONCO/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"ONCO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ONCO\",,,,,undefined,":{"symbol":"ONCO","market":"US","secType":"STK","nameCN":"Onconetix Inc.","latestPrice":0.7822,"timestamp":1789070400000,"preClose":0.8132,"halted":0,"volume":172907,"hourTrading":{"tag":"盘后","latestPrice":0.815,"preClose":0.7822,"latestTime":"17:52 EDT","volume":509,"amount":405.035223,"timestamp":1789077176029,"change":0.0328,"changeRate":0.041933,"amplitude":0.04743},"delay":0,"changeRate":-0.03812100344318744,"floatShares":3690899,"shares":3949107,"eps":-2.688,"marketStatus":"Post-Mkt","change":-0.031,"latestTime":"09-10 19:02:02 EDT","open":0.8186,"high":0.8439,"low":0.767,"amount":135766.2132953,"amplitude":0.094565,"askPrice":0.844,"askSize":1350,"bidPrice":0.76,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":-2.688,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789084800000},"marketStatusCode":4,"adr":0,"listingDate":1645160400000,"exchange":"NASDAQ","adjPreClose":0.8132,"preHourTrading":{"tag":"盘前","latestPrice":0.81,"preClose":0.8132,"latestTime":"09:10 EDT","volume":5359,"amount":4339.4647193,"timestamp":1789045847914,"change":-0.0032,"changeRate":-0.003935,"amplitude":0.047959},"postHourTrading":{"tag":"盘后","latestPrice":0.815,"preClose":0.7822,"latestTime":"17:52 EDT","volume":509,"amount":405.035223,"timestamp":1789077176029,"change":0.0328,"changeRate":0.041933,"amplitude":0.04743},"volumeRatio":0.100776},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ONCO\",,,,,undefined,":{"symbol":"ONCO","floatShares":3690899,"roa":"-27.03%","roe":"-105.23%","lyrEps":-828.1488,"volumeRatio":0.100776,"shares":3949107,"dividePrice":0,"high":0.8439,"amplitude":0.094565,"preClose":0.8132,"low":0.767,"week52Low":0.5868,"pbRate":"0.23","psRate":"4.78","week52High":209.5,"institutionHeld":0,"latestPrice":0.7822,"committee":-0.148936,"eps":-2.688,"divideRate":0,"volume":172907,"delay":0,"ttmEps":-2.688,"open":0.8186,"prevYearClose":78,"prevWeekClose":1.02,"prevMonthClose":0.6268,"prevQuarterClose":1.13,"fiveDayClose":0.6743,"twentyDayClose":0.8916,"sixtyDayClose":1.09},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ONCO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-13","symbol":"ONCO","fiscalQuarterEnding":"2026/06","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786593600000,"reportTimeType":"post","actualEps":-1.28},{"market":"US","date":"2026-05-21","symbol":"ONCO","defaultRemindTime":1779370200000,"type":"split","dateTimestamp":1779336000000,"forFactor":10,"toFactor":1,"ratio":10},{"market":"US","date":"2026-05-13","symbol":"ONCO","fiscalQuarterEnding":"2026/03","expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778644800000,"reportTimeType":"pre","actualEps":-6.71},{"market":"US","date":"2026-03-25","symbol":"ONCO","defaultRemindTime":1774445400000,"type":"split","dateTimestamp":1774411200000,"forFactor":5,"toFactor":1,"ratio":5},{"market":"US","date":"2026-03-13","symbol":"ONCO","fiscalQuarterEnding":"2025/12","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1773374400000,"reportTimeType":"post","actualEps":12.58}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ONCO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ONCO\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ONCO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ONCO","date":"2026-09-09","current":-0.290997,"percent":0.091463,"low":-0.968106,"twenty":-0.195533,"median":-0.083677,"eighty":-0.036816,"high":-0.007214,"avg":-0.133053,"sd":0.156877,"marketCap":3317249},"quantilePoints":[{"date":"2023-12-29","current":-0.201955,"twenty":-0.205826,"median":-0.201955,"eighty":-0.193917,"marketCap":3691085},{"date":"2024-01-05","current":-0.194459,"twenty":-0.201955,"median":-0.195264,"eighty":-0.193719,"marketCap":3554077},{"date":"2024-01-12","current":-0.190736,"twenty":-0.197125,"median":-0.193719,"eighty":-0.190736,"marketCap":3486030},{"date":"2024-01-19","current":-0.173836,"twenty":-0.19628,"median":-0.192899,"eighty":-0.180094,"marketCap":3177158},{"date":"2024-01-26","current":-0.342039,"twenty":-0.19628,"median":-0.189647,"eighty":-0.1728,"marketCap":6251352},{"date":"2024-02-02","current":-0.174037,"twenty":-0.202407,"median":-0.192246,"eighty":-0.173635,"marketCap":3180835},{"date":"2024-02-09","current":-0.164782,"twenty":-0.198091,"median":-0.186679,"eighty":-0.170436,"marketCap":3011681},{"date":"2024-02-16","current":-0.205696,"twenty":-0.198091,"median":-0.184801,"eighty":-0.168042,"marketCap":3759458},{"date":"2024-02-23","current":-0.206429,"twenty":-0.205989,"median":-0.188558,"eighty":-0.169852,"marketCap":3772853},{"date":"2024-03-01","current":-0.208872,"twenty":-0.20842,"median":-0.192572,"eighty":-0.172015,"marketCap":3817502},{"date":"2024-03-08","current":-0.22182,"twenty":-0.213025,"median":-0.193719,"eighty":-0.17277,"marketCap":4054143},{"date":"2024-03-15","current":-0.201665,"twenty":-0.217422,"median":-0.196597,"eighty":-0.172951,"marketCap":3685787},{"date":"2024-03-22","current":-0.203986,"twenty":-0.21515,"median":-0.197125,"eighty":-0.173514,"marketCap":3728204},{"date":"2024-03-28","current":-0.2002,"twenty":-0.212952,"median":-0.198734,"eighty":-0.173916,"marketCap":3658998},{"date":"2024-04-05","current":-0.204475,"twenty":-0.211193,"median":-0.198734,"eighty":-0.174238,"marketCap":3737134},{"date":"2024-04-12","current":-0.093154,"twenty":-0.209947,"median":-0.197125,"eighty":-0.174238,"marketCap":3484866},{"date":"2024-04-19","current":-0.079022,"twenty":-0.209385,"median":-0.195935,"eighty":-0.172739,"marketCap":2956187},{"date":"2024-04-26","current":-0.07186,"twenty":-0.2087,"median":-0.194214,"eighty":-0.166713,"marketCap":2688255},{"date":"2024-05-03","current":-0.067443,"twenty":-0.208428,"median":-0.193586,"eighty":-0.15949,"marketCap":2523030},{"date":"2024-05-10","current":-0.066787,"twenty":-0.208202,"median":-0.192246,"eighty":-0.083892,"marketCap":2498469},{"date":"2024-05-17","current":-0.084155,"twenty":-0.207504,"median":-0.190061,"eighty":-0.075083,"marketCap":3148205},{"date":"2024-05-24","current":-0.069112,"twenty":-0.206722,"median":-0.188558,"eighty":-0.074211,"marketCap":3157136},{"date":"2024-05-31","current":-0.116278,"twenty":-0.206282,"median":-0.18621,"eighty":-0.07464,"marketCap":5311760},{"date":"2024-06-07","current":-0.08705,"twenty":-0.205452,"median":-0.178162,"eighty":-0.074985,"marketCap":3976563},{"date":"2024-06-14","current":-0.070578,"twenty":-0.204475,"median":-0.174289,"eighty":-0.074605,"marketCap":3224120},{"date":"2024-06-21","current":-0.075759,"twenty":-0.204269,"median":-0.173433,"eighty":-0.074474,"marketCap":3460793},{"date":"2024-06-28","current":-0.100148,"twenty":-0.204171,"median":-0.17293,"eighty":-0.07408,"marketCap":4574945},{"date":"2024-07-05","current":-0.078056,"twenty":-0.203986,"median":-0.171849,"eighty":-0.074605,"marketCap":3565733},{"date":"2024-07-12","current":-0.070578,"twenty":-0.203986,"median":-0.1678,"eighty":-0.07371,"marketCap":3224120},{"date":"2024-07-15","current":-0.074977,"twenty":-0.203742,"median":-0.166895,"eighty":-0.073758,"marketCap":3425069},{"date":"2024-08-02","current":-0.097024,"twenty":-0.203498,"median":-0.165989,"eighty":-0.073806,"marketCap":4432207},{"date":"2024-08-09","current":-0.087113,"twenty":-0.202765,"median":-0.164732,"eighty":-0.074211,"marketCap":3979455},{"date":"2024-08-16","current":-0.091286,"twenty":-0.202441,"median":-0.148887,"eighty":-0.074675,"marketCap":4170088},{"date":"2024-08-23","current":-0.103936,"twenty":-0.201937,"median":-0.114182,"eighty":-0.074801,"marketCap":4747943},{"date":"2024-08-30","current":-0.075134,"twenty":-0.201812,"median":-0.103936,"eighty":-0.074889,"marketCap":3991369},{"date":"2024-09-06","current":-0.071275,"twenty":-0.201372,"median":-0.101719,"eighty":-0.07464,"marketCap":3786324},{"date":"2024-09-13","current":-0.074303,"twenty":-0.199931,"median":-0.100613,"eighty":-0.073472,"marketCap":3947190},{"date":"2024-09-20","current":-0.06477,"twenty":-0.198832,"median":-0.097806,"eighty":-0.072904,"marketCap":3440758},{"date":"2024-09-27","current":-0.047041,"twenty":-0.198734,"median":-0.097089,"eighty":-0.072123,"marketCap":2498940},{"date":"2024-10-04","current":-0.702586,"twenty":-0.201861,"median":-0.097806,"eighty":-0.072322,"marketCap":37323522},{"date":"2024-10-11","current":-0.804153,"twenty":-0.203742,"median":-0.100613,"eighty":-0.072761,"marketCap":42719049},{"date":"2024-10-18","current":-0.880664,"twenty":-0.205452,"median":-0.101719,"eighty":-0.072874,"marketCap":46783580},{"date":"2024-10-25","current":-0.626146,"twenty":-0.208304,"median":-0.106675,"eighty":-0.072904,"marketCap":33262793},{"date":"2024-10-31","current":-0.46218,"twenty":-0.209727,"median":-0.114182,"eighty":-0.073022,"marketCap":24552412},{"date":"2024-11-08","current":-0.379425,"twenty":-0.217422,"median":-0.148887,"eighty":-0.073022,"marketCap":20156203},{"date":"2024-11-15","current":-0.254511,"twenty":-0.219865,"median":-0.164732,"eighty":-0.073315,"marketCap":13520416},{"date":"2024-11-22","current":-0.17644,"twenty":-0.219499,"median":-0.165989,"eighty":-0.073412,"marketCap":9373049},{"date":"2024-11-29","current":-0.107738,"twenty":-0.218815,"median":-0.165889,"eighty":-0.07365,"marketCap":5723366},{"date":"2024-12-06","current":-0.098369,"twenty":-0.217666,"median":-0.160355,"eighty":-0.073901,"marketCap":5225682},{"date":"2024-12-13","current":-0.075065,"twenty":-0.217422,"median":-0.144138,"eighty":-0.074232,"marketCap":3873640},{"date":"2024-12-20","current":-0.057866,"twenty":-0.214393,"median":-0.114182,"eighty":-0.073393,"marketCap":2986104},{"date":"2024-12-27","current":-0.056259,"twenty":-0.21261,"median":-0.110145,"eighty":-0.072963,"marketCap":2903156},{"date":"2025-01-03","current":-0.104658,"twenty":-0.211193,"median":-0.107738,"eighty":-0.072874,"marketCap":5400701},{"date":"2025-01-10","current":-0.087844,"twenty":-0.210021,"median":-0.107738,"eighty":-0.072904,"marketCap":4533072},{"date":"2025-01-17","current":-0.082411,"twenty":-0.209556,"median":-0.104481,"eighty":-0.073022,"marketCap":4252710},{"date":"2025-01-24","current":-0.077155,"twenty":-0.208872,"median":-0.103034,"eighty":-0.073022,"marketCap":3981472},{"date":"2025-01-31","current":-0.090802,"twenty":-0.208442,"median":-0.10198,"eighty":-0.073315,"marketCap":4685695},{"date":"2025-02-07","current":-0.105075,"twenty":-0.208406,"median":-0.10224,"eighty":-0.073412,"marketCap":5422267},{"date":"2025-02-14","current":-0.087185,"twenty":-0.207895,"median":-0.101296,"eighty":-0.07371,"marketCap":4499063},{"date":"2025-02-21","current":-0.067511,"twenty":-0.207113,"median":-0.100929,"eighty":-0.073393,"marketCap":3483788},{"date":"2025-02-28","current":-0.049315,"twenty":-0.206527,"median":-0.100148,"eighty":-0.072875,"marketCap":2544824},{"date":"2025-03-07","current":-0.036777,"twenty":-0.205843,"median":-0.098528,"eighty":-0.072195,"marketCap":1897835},{"date":"2025-03-14","current":-0.020864,"twenty":-0.204719,"median":-0.098369,"eighty":-0.071225,"marketCap":1076656},{"date":"2025-03-21","current":-0.020944,"twenty":-0.204269,"median":-0.097978,"eighty":-0.070572,"marketCap":1080803},{"date":"2025-03-28","current":-0.017312,"twenty":-0.204032,"median":-0.097741,"eighty":-0.069818,"marketCap":893342},{"date":"2025-04-04","current":-0.0122,"twenty":-0.203986,"median":-0.097063,"eighty":-0.069089,"marketCap":629570},{"date":"2025-04-11","current":-0.009323,"twenty":-0.203009,"median":-0.096444,"eighty":-0.068134,"marketCap":481094},{"date":"2025-04-17","current":-0.00958,"twenty":-0.202765,"median":-0.095559,"eighty":-0.067511,"marketCap":494366},{"date":"2025-04-25","current":-0.011091,"twenty":-0.202279,"median":-0.093131,"eighty":-0.066512,"marketCap":572336},{"date":"2025-05-02","current":-0.012554,"twenty":-0.201928,"median":-0.092586,"eighty":-0.065058,"marketCap":647818},{"date":"2025-05-09","current":-0.011702,"twenty":-0.201763,"median":-0.090913,"eighty":-0.063884,"marketCap":603856},{"date":"2025-05-16","current":-0.011991,"twenty":-0.200786,"median":-0.088907,"eighty":-0.05784,"marketCap":618787},{"date":"2025-05-23","current":-0.023761,"twenty":-0.199394,"median":-0.088096,"eighty":-0.054651,"marketCap":1226160},{"date":"2025-05-30","current":-0.068768,"twenty":-0.198807,"median":-0.087659,"eighty":-0.054651,"marketCap":3548673},{"date":"2025-06-06","current":-0.052528,"twenty":-0.198734,"median":-0.087113,"eighty":-0.054651,"marketCap":3082910},{"date":"2025-06-13","current":-0.058572,"twenty":-0.19856,"median":-0.086807,"eighty":-0.054651,"marketCap":3286955},{"date":"2025-06-20","current":-0.037197,"twenty":-0.198065,"median":-0.086363,"eighty":-0.052105,"marketCap":2087452},{"date":"2025-06-27","current":-0.043242,"twenty":-0.196958,"median":-0.084244,"eighty":-0.047082,"marketCap":2426662},{"date":"2025-07-03","current":-0.043242,"twenty":-0.196291,"median":-0.084155,"eighty":-0.044358,"marketCap":2426662},{"date":"2025-07-11","current":-0.040638,"twenty":-0.196069,"median":-0.082194,"eighty":-0.043707,"marketCap":2280541},{"date":"2025-07-18","current":-0.033199,"twenty":-0.195802,"median":-0.081722,"eighty":-0.043242,"marketCap":1863050},{"date":"2025-07-25","current":-0.033571,"twenty":-0.194459,"median":-0.079938,"eighty":-0.040587,"marketCap":1883925},{"date":"2025-08-01","current":-0.033106,"twenty":-0.194214,"median":-0.079059,"eighty":-0.039615,"marketCap":1857832},{"date":"2025-08-08","current":-0.024829,"twenty":-0.194214,"median":-0.078385,"eighty":-0.038313,"marketCap":1393374},{"date":"2025-08-15","current":-0.08511,"twenty":-0.193719,"median":-0.078056,"eighty":-0.037197,"marketCap":4776225},{"date":"2025-08-22","current":-0.098303,"twenty":-0.193453,"median":-0.078868,"eighty":-0.037476,"marketCap":4343428},{"date":"2025-08-29","current":-0.10495,"twenty":-0.192899,"median":-0.079376,"eighty":-0.038127,"marketCap":4637112},{"date":"2025-09-05","current":-0.100402,"twenty":-0.192377,"median":-0.080109,"eighty":-0.038276,"marketCap":4436170},{"date":"2025-09-12","current":-0.109498,"twenty":-0.191038,"median":-0.081809,"eighty":-0.038536,"marketCap":4838053},{"date":"2025-09-19","current":-0.10495,"twenty":-0.190587,"median":-0.082411,"eighty":-0.03889,"marketCap":4637112},{"date":"2025-09-26","current":-0.111597,"twenty":-0.189768,"median":-0.084184,"eighty":-0.039262,"marketCap":4930795},{"date":"2025-10-03","current":-0.110197,"twenty":-0.189377,"median":-0.08511,"eighty":-0.039559,"marketCap":4868967},{"date":"2025-10-10","current":-0.144131,"twenty":-0.188712,"median":-0.086363,"eighty":-0.039737,"marketCap":6368300},{"date":"2025-10-17","current":-0.12174,"twenty":-0.188197,"median":-0.086815,"eighty":-0.039794,"marketCap":5378958},{"date":"2025-10-24","current":-0.117582,"twenty":-0.186589,"median":-0.087149,"eighty":-0.040024,"marketCap":5195267},{"date":"2025-10-31","current":-0.132966,"twenty":-0.185889,"median":-0.087844,"eighty":-0.040486,"marketCap":5875000},{"date":"2025-11-07","current":-0.093673,"twenty":-0.185003,"median":-0.088278,"eighty":-0.040628,"marketCap":4138852},{"date":"2025-11-14","current":-0.085873,"twenty":-0.182146,"median":-0.088907,"eighty":-0.041415,"marketCap":3794224},{"date":"2025-11-21","current":-0.073999,"twenty":-0.178698,"median":-0.088096,"eighty":-0.042023,"marketCap":3636356},{"date":"2025-11-28","current":-0.088291,"twenty":-0.177065,"median":-0.087968,"eighty":-0.042796,"marketCap":4338657},{"date":"2025-12-05","current":-0.09369,"twenty":-0.175481,"median":-0.088091,"eighty":-0.043242,"marketCap":4603970},{"date":"2025-12-12","current":-0.073364,"twenty":-0.174661,"median":-0.088061,"eighty":-0.043242,"marketCap":3605143},{"date":"2025-12-19","current":-0.058437,"twenty":-0.174238,"median":-0.087474,"eighty":-0.043521,"marketCap":2871629},{"date":"2025-12-26","current":-0.048274,"twenty":-0.173957,"median":-0.087113,"eighty":-0.043819,"marketCap":2372215},{"date":"2026-01-02","current":-0.049365,"twenty":-0.173675,"median":-0.086815,"eighty":-0.04406,"marketCap":2425823},{"date":"2026-01-09","current":-0.054428,"twenty":-0.172991,"median":-0.086363,"eighty":-0.044414,"marketCap":2674625},{"date":"2026-01-16","current":-0.050947,"twenty":-0.1728,"median":-0.085192,"eighty":-0.044693,"marketCap":2503574},{"date":"2026-01-23","current":-0.05158,"twenty":-0.172679,"median":-0.084244,"eighty":-0.044916,"marketCap":2534674},{"date":"2026-01-30","current":-0.04715,"twenty":-0.171019,"median":-0.084,"eighty":-0.044916,"marketCap":2316972},{"date":"2026-02-06","current":-0.038606,"twenty":-0.170195,"median":-0.082411,"eighty":-0.044637,"marketCap":1897118},{"date":"2026-02-13","current":-0.033543,"twenty":-0.168633,"median":-0.081838,"eighty":-0.044358,"marketCap":1648315},{"date":"2026-02-20","current":-0.022784,"twenty":-0.168208,"median":-0.081672,"eighty":-0.043242,"marketCap":1119610},{"date":"2026-02-27","current":-0.020885,"twenty":-0.16786,"median":-0.08037,"eighty":-0.042023,"marketCap":1026309},{"date":"2026-03-06","current":-0.018037,"twenty":-0.166351,"median":-0.079913,"eighty":-0.040024,"marketCap":886358},{"date":"2026-03-13","current":-0.018123,"twenty":-0.165909,"median":-0.079059,"eighty":-0.039262,"marketCap":890557},{"date":"2026-03-20","current":-0.11953,"twenty":-0.165003,"median":-0.079913,"eighty":-0.039559,"marketCap":1677281},{"date":"2026-03-27","current":-0.159406,"twenty":-0.164701,"median":-0.08037,"eighty":-0.039737,"marketCap":2236837},{"date":"2026-04-02","current":-0.092599,"twenty":-0.161516,"median":-0.08037,"eighty":-0.039787,"marketCap":1299376},{"date":"2026-04-10","current":-0.060244,"twenty":-0.15738,"median":-0.079913,"eighty":-0.039968,"marketCap":845370},{"date":"2026-04-17","current":-0.037529,"twenty":-0.154491,"median":-0.079059,"eighty":-0.039706,"marketCap":526624},{"date":"2026-04-24","current":-0.032907,"twenty":-0.151386,"median":-0.078385,"eighty":-0.038821,"marketCap":461766},{"date":"2026-05-01","current":-0.034295,"twenty":-0.149362,"median":-0.078056,"eighty":-0.03805,"marketCap":481237},{"date":"2026-05-08","current":-0.01995,"twenty":-0.148907,"median":-0.07745,"eighty":-0.037508,"marketCap":279942},{"date":"2026-05-15","current":-0.027856,"twenty":-0.146038,"median":-0.077155,"eighty":-0.036893,"marketCap":270241},{"date":"2026-05-22","current":-0.008714,"twenty":-0.144134,"median":-0.07622,"eighty":-0.036392,"marketCap":84536},{"date":"2026-05-29","current":-0.008357,"twenty":-0.143261,"median":-0.075867,"eighty":-0.03594,"marketCap":81071},{"date":"2026-06-05","current":-0.007428,"twenty":-0.140662,"median":-0.075552,"eighty":-0.034612,"marketCap":72063},{"date":"2026-06-12","current":-0.128811,"twenty":-0.136741,"median":-0.075656,"eighty":-0.034377,"marketCap":1249638},{"date":"2026-06-18","current":-0.378573,"twenty":-0.141309,"median":-0.075867,"eighty":-0.034557,"marketCap":3672665},{"date":"2026-06-26","current":-0.372827,"twenty":-0.148926,"median":-0.076297,"eighty":-0.034835,"marketCap":3616923},{"date":"2026-07-02","current":-0.410955,"twenty":-0.15603,"median":-0.077155,"eighty":-0.035058,"marketCap":3986811},{"date":"2026-07-10","current":-0.374806,"twenty":-0.165889,"median":-0.07745,"eighty":-0.035337,"marketCap":3636119},{"date":"2026-07-17","current":-0.301253,"twenty":-0.168633,"median":-0.078056,"eighty":-0.035934,"marketCap":2922554},{"date":"2026-07-24","current":-0.300454,"twenty":-0.17283,"median":-0.078385,"eighty":-0.035949,"marketCap":2914802},{"date":"2026-07-31","current":-0.299236,"twenty":-0.174138,"median":-0.07904,"eighty":-0.036107,"marketCap":2902989},{"date":"2026-08-07","current":-0.34387,"twenty":-0.178698,"median":-0.079767,"eighty":-0.036162,"marketCap":3336001},{"date":"2026-08-14","current":-0.335765,"twenty":-0.186589,"median":-0.080239,"eighty":-0.036467,"marketCap":3257372},{"date":"2026-08-21","current":-0.258337,"twenty":-0.189768,"median":-0.081622,"eighty":-0.036624,"marketCap":2634054},{"date":"2026-08-28","current":-0.244781,"twenty":-0.19301,"median":-0.081838,"eighty":-0.036648,"marketCap":2495835},{"date":"2026-09-04","current":-0.286223,"twenty":-0.194263,"median":-0.082411,"eighty":-0.036751,"marketCap":2918390},{"date":"2026-09-09","current":-0.325342,"twenty":-0.195533,"median":-0.083677,"eighty":-0.036816,"marketCap":3317249}],"updateTime":1789081322318},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ONCO\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2638596182","title":"Oncopeptides Accelerates CEE Expansion for Pepaxti via Exclusive Salus Distribution Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2638596182","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638596182?lang=en_us&edition=fundamental","pubTime":"2026-05-26 14:55","pubTimestamp":1779778543,"startTime":"0","endTime":"0","summary":"The latest update is out from Oncopeptides AB ( ($SE:ONCO) ). Oncopeptides AB has signed an exclusive agreement with Salus Group affiliate SALUS Ve...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/oncopeptides-accelerates-cee-expansion-for-pepaxti-via-exclusive-salus-distribution-deal?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/oncopeptides-accelerates-cee-expansion-for-pepaxti-via-exclusive-salus-distribution-deal?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ONCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637745438","title":"Onconetix Inc trading halted, news pending","url":"https://stock-news.laohu8.com/highlight/detail?id=2637745438","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637745438?lang=en_us&edition=fundamental","pubTime":"2026-05-21 07:50","pubTimestamp":1779321010,"startTime":"0","endTime":"0","summary":"19:50 EDT Onconetix (ONCO) Inc trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving breaking f...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/onconetix-inc-trading-halted-news-pending-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/onconetix-inc-trading-halted-news-pending-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ONCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636586868","title":"BUZZ-U.S. STOCKS ON THE MOVE-T1 Energy, Home Depot, X-Energy","url":"https://stock-news.laohu8.com/highlight/detail?id=2636586868","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636586868?lang=en_us&edition=fundamental","pubTime":"2026-05-19 23:48","pubTimestamp":1779205729,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-T1 Energy, Home Depot, X-Energy  Workspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newslett","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nL6N41W134:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMS","WDAY","WOK","GOOY","HIMZ","VPG","GOOW","RLAY","NVD2.UK","XE","CVNA","DRVN","AMST","NVDS.UK","SKLZ","ONTO","KR","NVDW","NOW","AS","BX","INM","NVD3.UK","SITM","TE","GGLL","NVDQ","CTRE","HMYY","ONCO","BDX","GOOGL","HIYY","HSBA.UK","2NVD.UK","ALB","GOOX","CODX","NVDA","DIPS","HIMY","VRT","WNW","CRM","CRMG","HD","INTU","HOTH","YMAT","GOU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636856077","title":"BRIEF-Onconetix, Inc. Announces 1-For-10 Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2636856077","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636856077?lang=en_us&edition=fundamental","pubTime":"2026-05-19 20:40","pubTimestamp":1779194452,"startTime":"0","endTime":"0","summary":"BRIEF-Onconetix, Inc. Announces 1-For-10 Reverse Stock SplitMay 19 (Reuters) - Onconetix Inc ONCO.O:ONCONETIX, INC. ANNOUNCES 1-FOR-10 REVERSE STOCK SPLITSource text: ID:nGNE7Wj1gsFurther company coverage: ONCO.O ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nFWN41W06F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONCO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636856913","title":"BRIEF-Realbotix Provides Update On Nasdaq Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=2636856913","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636856913?lang=en_us&edition=fundamental","pubTime":"2026-05-19 20:23","pubTimestamp":1779193438,"startTime":"0","endTime":"0","summary":"BRIEF-Realbotix Provides Update On Nasdaq ListingMay 19 (Reuters) - Realbotix Corp XBOT.V:REALBOTIX PROVIDES UPDATE ON NASDAQ LISTINGREALBOTIX CORP - TO LIST REALBOTIX LLC ON NASDAQ VIA REVERSE TAKEOV","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nTUA1Y8YW9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ONCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636885562","title":"Onconetix, Inc. Announces 1-for-10 Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2636885562","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636885562?lang=en_us&edition=fundamental","pubTime":"2026-05-19 20:00","pubTimestamp":1779192000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nTUARLNC1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ONCO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636853132","title":"Realbotix says Nasdaq reverse takeover listing for unit expected to close by October 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2636853132","media":"Reuters","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636853132?lang=en_us&edition=fundamental","pubTime":"2026-05-19 19:30","pubTimestamp":1779190240,"startTime":"0","endTime":"0","summary":"Realbotix provided an update on its plan to list its wholly owned unit Realbotix LLC on the Nasdaq Capital Market via a reverse takeover with Onconetix.The deal would shift the commercial robotics and AI business into a Nasdaq-listed entity, with Realbotix expected to retain a 75-90% ownership stake.The transaction remains subject to Onconetix shareholder and regulatory clearances, with closing targeted by October 2026.Realbotix said no action is required from its shareholders, citing no change to the parent-company structure, no parent-level share issuance, and no share consolidation.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Realbotix Corp. published the original content used to generate this news brief via Business Wire  on May","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nNDL7GyLq0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONCO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636853437","title":"Realbotix Corp - to Retain 75–90% Ownership of Realllc After Nasdaq Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=2636853437","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636853437?lang=en_us&edition=fundamental","pubTime":"2026-05-19 19:30","pubTimestamp":1779190200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nTUA1Y8YW9:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ONCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636838157","title":"Onconetix (ONCO) Stock Surges Over 23% Overnight: Why Is It Moving?","url":"https://stock-news.laohu8.com/highlight/detail?id=2636838157","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636838157?lang=en_us&edition=fundamental","pubTime":"2026-05-19 15:03","pubTimestamp":1779174235,"startTime":"0","endTime":"0","summary":"Onconetix Inc. shares soared 23.65% after hours following clinical progress updates, new study initiation and developments in prostate cancer diagnostics.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/equities/26/05/52654323/onconetix-onco-stock-surges-over-23-overnight-why-is-it-moving","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4150","ONCO","BK4139","BK4533","RSI","BK4084","BK4588","PSA","BK4585","BK4600","BK4112","BK4595","BKKT","BK4217"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635738313","title":"Onconetix Q1 EPS $(6.71) Up From $(225.25) YoY, Sales $21.457K Down From $101.630K YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2635738313","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635738313?lang=en_us&edition=fundamental","pubTime":"2026-05-13 21:48","pubTimestamp":1778680080,"startTime":"0","endTime":"0","summary":"Onconetix (NASDAQ:ONCO) reported quarterly losses of $(6.71) per share. This is a 97.02 percent increase over losses of $(225.25) per share from the same period last year.  The company reported $21.457 thousand in sales","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52524131/onconetix-q1-eps-6-71-up-from-225-25-yoy-sales-21-457k-down-from-101-630k-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ONCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635878091","title":"Onconetix unit Proteomedix launches Proclarix U.S. validation study with Labcorp","url":"https://stock-news.laohu8.com/highlight/detail?id=2635878091","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635878091?lang=en_us&edition=fundamental","pubTime":"2026-05-13 21:26","pubTimestamp":1778678776,"startTime":"0","endTime":"0","summary":"Onconetix reported Q1 2026 progress at wholly owned Swiss subsidiary Proteomedix, highlighting two peer-reviewed studies supporting Proclarix use to cut unnecessary prostate biopsies.Proteomedix initiated PRIME, a US multi-center validation study with Labcorp, enrolling first participants with target up to 500 men across multiple ethnicities.European rollout advanced, with Proclarix offered in a UK real-world screening initiative that ran close to 100 tests during Q1, alongside steps toward expansion into Turkey.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nNDL1SyC78:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","IE00BN0W2V16.EUR","SG9999014013.SGD","SG9999014005.SGD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","IE00BKPKM429.USD","IE00BN0W2W23.USD","SG9999014039.USD","LU0314104364.USD","LU0006061336.USD","NDAQ","ONCO","IE00BN0W2T93.GBP","IE00B3QW5Z07.USD","BK4588","LU2210149790.SGD","LU2210150020.SGD","LU1059921491.USD","SG9999014021.USD","LU0048573561.USD","LH","BK4550","LU0742534661.SGD","BK4585","LU0251142724.SGD","LU2237438978.USD","BK4196","LU2095319765.USD","LU0251131958.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635873317","title":"Onconetix Q1 net loss narrows 50.7% to $4.21 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635873317","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635873317?lang=en_us&edition=fundamental","pubTime":"2026-05-13 20:52","pubTimestamp":1778676776,"startTime":"0","endTime":"0","summary":"Onconetix posted net loss of $4.21 million, narrowing from year-earlier net loss applicable to common stockholders of $9.72 million.Revenue fell 78.9% to $21,457, swinging gross profit to gross loss of $1,655.Operating loss narrowed to $10.23 million as total operating expenses fell 19% to $10.22 million, including goodwill impairment of $8.13 million.Cash totaled $3.7 million at March 31, 2026; Onconetix said balance was not sufficient to fund operations through end of December 2026 while it continues to commercialize Proclarix and pursue Realbotix share-exchange closing conditions, including at least $12.5 million in Net Cash.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Onconetix Inc. published the original content used to generat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nNDL6cQHLV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ONCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635778995","title":"Oncopeptides showcases new Pepaxti data to bolster multiple myeloma positioning","url":"https://stock-news.laohu8.com/highlight/detail?id=2635778995","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635778995?lang=en_us&edition=fundamental","pubTime":"2026-05-13 19:16","pubTimestamp":1778670963,"startTime":"0","endTime":"0","summary":"Oncopeptides AB ( ($SE:ONCO) ) has shared an announcement. Oncopeptides AB announced new clinical and real-world evidence for its multiple myeloma ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/oncopeptides-showcases-new-pepaxti-data-to-bolster-multiple-myeloma-positioning?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/oncopeptides-showcases-new-pepaxti-data-to-bolster-multiple-myeloma-positioning?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2152927971.USD","LU0823039010.USD","LU0175139822.USD","BK4554","BK4551","SG9999002620.SGD","LU1839390173.USD","LU0210637038.USD","LU0516422440.USD","LU0264606111.USD","LU2065170008.USD","SGXZ58947870.SGD","LU0072462343.USD","LU2360107671.USD","LU0345775950.USD","LU0572940350.SGD","LU2045819591.USD","LU0532188223.SGD","LU0516422952.EUR","LU0251143029.SGD","LU0979878070.USD","LU0048573645.USD","IE0034224299.USD","SG9999013486.USD","LU2008162690.USD","LU0516422366.SGD","BK4588","LU2065171402.SGD","BK4566","LU0499858602.USD","SG9999002406.SGD","LU0441851309.USD","LU2543165471.USD","BK4220","LU1242518931.SGD","IE0001KFT4U8.USD","LU0348788117.USD","LU0289960550.SGD","SG9999002679.SGD","LU1770036033.HKD","SG9999002414.USD","LU0261945553.USD","LU0572939691.SGD","LU0589944569.HKD","LU1861220207.SGD","SG9999002604.SGD","LU0516423174.USD","LU2125910849.SGD","SG9999013478.USD","IE00BD6J9T35.USD","SG9999001135.SGD","LU1048588211.SGD","SG9999005177.SGD","BK4085","SG9999014492.USD","IE0031814969.USD","LU1861217088.USD","LU0499858438.USD","LU0823038988.USD","LU0345776255.USD","LU2065169927.USD","LU2125910500.SGD","ONCO","BK4535","LU0516423091.SGD","LU2177674079.SGD","BK4548","BK4503","SG9999013460.SGD","LU2065171311.SGD","LU2238330802.EUR","SG9999014484.SGD","LU0737861269.HKD","BK4581","SG9999006266.SGD","BK4585","LU1242518857.USD","SG9999004360.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635203997","title":"Oncopeptides posts strong Q1 sales growth as Pepaxti momentum builds in Europe","url":"https://stock-news.laohu8.com/highlight/detail?id=2635203997","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635203997?lang=en_us&edition=fundamental","pubTime":"2026-05-13 15:00","pubTimestamp":1778655621,"startTime":"0","endTime":"0","summary":"Oncopeptides AB ( ($SE:ONCO) ) has issued an announcement. Oncopeptides reported a strong start to 2026, with first-quarter net sales rising 91 per...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/oncopeptides-posts-strong-q1-sales-growth-as-pepaxti-momentum-builds-in-europe?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/oncopeptides-posts-strong-q1-sales-growth-as-pepaxti-momentum-builds-in-europe?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0251143029.SGD","SG9999013486.USD","LU2008162690.USD","LU0499858438.USD","LU2177674079.SGD","SG9999002679.SGD","IE0001KFT4U8.USD","LU1242518857.USD","BK4581","LU0072462343.USD","LU0979878070.USD","LU1048588211.SGD","LU0516423091.SGD","LU2125910500.SGD","SG9999013478.USD","LU0264606111.USD","LU0516422366.SGD","LU0210637038.USD","SG9999001135.SGD","IE0031814969.USD","SG9999014484.SGD","LU2065171402.SGD","LU0823039010.USD","LU2360107671.USD","BK4535","BK4554","LU1242518931.SGD","LU1770036033.HKD","LU0572939691.SGD","LU0048573645.USD","LU2238330802.EUR","SG9999006266.SGD","SG9999002604.SGD","IE0034224299.USD","LU2125910849.SGD","BK4588","LU0516423174.USD","SG9999002414.USD","LU1861220207.SGD","LU0261945553.USD","IE00BD6J9T35.USD","LU0348788117.USD","LU0289960550.SGD","LU0572940350.SGD","LU0589944569.HKD","LU2543165471.USD","LU0516422952.EUR","LU2045819591.USD","SG9999004360.SGD","BK4566","LU0345776255.USD","BK4548","LU0823038988.USD","LU2065169927.USD","BK4585","BK4551","SG9999002406.SGD","LU2152927971.USD","BK4503","SG9999013460.SGD","BK4085","LU0441851309.USD","LU0532188223.SGD","LU1839390173.USD","SG9999005177.SGD","LU0737861269.HKD","LU0345775950.USD","LU2065171311.SGD","BK4220","LU1861217088.USD","SGXZ58947870.SGD","LU0499858602.USD","LU0516422440.USD","SG9999014492.USD","LU0175139822.USD","ONCO","LU2065170008.USD","SG9999002620.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634729767","title":"Onconetix:Prospectus Relates to Offer & Sale From Time to Time by Keystone Capital Partners of up to 25 Mln Shares of Common Stock of Co","url":"https://stock-news.laohu8.com/highlight/detail?id=2634729767","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634729767?lang=en_us&edition=fundamental","pubTime":"2026-05-12 18:11","pubTimestamp":1778580661,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nFWN41P0V6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ONCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634408177","title":"Oncopeptides Targets Third-Line Multiple Myeloma Indication to Boost Pepaxti Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2634408177","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634408177?lang=en_us&edition=fundamental","pubTime":"2026-05-11 14:58","pubTimestamp":1778482687,"startTime":"0","endTime":"0","summary":"Oncopeptides AB ( ($SE:ONCO) ) just unveiled an announcement. Oncopeptides plans to seek a Type II variation from the European Medicines Agency to ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/oncopeptides-targets-third-line-multiple-myeloma-indication-to-boost-pepaxti-growth?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/oncopeptides-targets-third-line-multiple-myeloma-indication-to-boost-pepaxti-growth?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0572939691.SGD","SG9999005177.SGD","LU0532188223.SGD","BK4503","IE0031814969.USD","LU2065171402.SGD","LU0589944569.HKD","LU2152927971.USD","LU0516422366.SGD","LU2125910849.SGD","LU2238330802.EUR","SG9999001135.SGD","SG9999002604.SGD","ONCO","SG9999004360.SGD","SG9999002406.SGD","LU0823038988.USD","LU2360107671.USD","SG9999002679.SGD","SG9999002414.USD","LU0264606111.USD","BK4554","LU1861220207.SGD","LU0345775950.USD","LU0210637038.USD","BK4548","SG9999014484.SGD","LU0072462343.USD","LU1839390173.USD","LU0516423091.SGD","LU2065171311.SGD","LU0516422952.EUR","LU0516423174.USD","LU2065170008.USD","LU0499858602.USD","LU1770036033.HKD","LU1242518857.USD","IE0001KFT4U8.USD","BK4581","LU0441851309.USD","BK4588","IE00BD6J9T35.USD","LU0261945553.USD","LU0572940350.SGD","BK4566","LU0175139822.USD","SG9999013460.SGD","LU0048573645.USD","SG9999013486.USD","BK4551","LU0499858438.USD","SG9999013478.USD","LU2125910500.SGD","LU0979878070.USD","LU0823039010.USD","LU0516422440.USD","BK4535","LU0289960550.SGD","LU1861217088.USD","LU2543165471.USD","LU0348788117.USD","SG9999014492.USD","SG9999002620.SGD","LU2177674079.SGD","LU0345776255.USD","LU2065169927.USD","LU2008162690.USD","LU2045819591.USD","LU0251143029.SGD","BK4085","LU1242518931.SGD","BK4220","SG9999006266.SGD","BK4585","LU0737861269.HKD","SGXZ58947870.SGD","LU1048588211.SGD","IE0034224299.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633909675","title":"Oncopeptides Sets May 13 Webcast for Q1 2026 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2633909675","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633909675?lang=en_us&edition=fundamental","pubTime":"2026-05-06 14:41","pubTimestamp":1778049670,"startTime":"0","endTime":"0","summary":"Oncopeptides AB ( ($SE:ONCO) ) has provided an update. Oncopeptides AB, a Stockholm-listed biotech focused on targeted therapies for hard-to-treat ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/oncopeptides-sets-may-13-webcast-for-q1-2026-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/oncopeptides-sets-may-13-webcast-for-q1-2026-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SGXZ58947870.SGD","BK4535","SG9999005177.SGD","LU0345776255.USD","IE00BD6J9T35.USD","LU2045819591.USD","LU0516422366.SGD","LU0979878070.USD","LU2543165471.USD","LU1048588211.SGD","LU0210637038.USD","BK4551","LU1861217088.USD","LU2065169927.USD","IE0031814969.USD","LU2152927971.USD","LU0175139822.USD","LU2008162690.USD","LU0572940350.SGD","LU0499858602.USD","LU0072462343.USD","SG9999002620.SGD","LU1861220207.SGD","LU0348788117.USD","BK4220","SG9999002679.SGD","SG9999002414.USD","BK4585","IE0034224299.USD","SG9999013486.USD","LU0499858438.USD","LU2360107671.USD","LU1242518857.USD","BK4548","LU1839390173.USD","LU0261945553.USD","LU0516422440.USD","LU2125910849.SGD","LU0048573645.USD","LU2065170008.USD","LU2065171402.SGD","LU0737861269.HKD","SG9999001135.SGD","LU0532188223.SGD","LU0345775950.USD","LU0516422952.EUR","LU0251143029.SGD","BK4085","SG9999002406.SGD","SG9999004360.SGD","LU0264606111.USD","LU0289960550.SGD","BK4503","IE0001KFT4U8.USD","BK4554","LU0572939691.SGD","SG9999013478.USD","SG9999006266.SGD","SG9999002604.SGD","LU0516423091.SGD","LU0516423174.USD","LU1242518931.SGD","LU2125910500.SGD","LU1770036033.HKD","SG9999013460.SGD","BK4588","LU2177674079.SGD","LU0589944569.HKD","BK4581","LU2238330802.EUR","SG9999014484.SGD","LU0823039010.USD","SG9999014492.USD","LU0823038988.USD","ONCO","BK4566","LU2065171311.SGD","LU0441851309.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631453525","title":"Onconetix files to sell 25M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2631453525","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631453525?lang=en_us&edition=fundamental","pubTime":"2026-04-29 04:18","pubTimestamp":1777407534,"startTime":"0","endTime":"0","summary":"16:12 EDT Onconetix (ONCO) files to sell 25M shares of common stock for holders Published first on TheFly – the ultimate source for real-time, mark...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/onconetix-files-to-sell-25m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/onconetix-files-to-sell-25m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ONCO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631749581","title":"Oncopeptides Marks Growth Phase as 2025 Annual Report Highlights Pepaxti Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=2631749581","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631749581?lang=en_us&edition=fundamental","pubTime":"2026-04-29 00:05","pubTimestamp":1777392355,"startTime":"0","endTime":"0","summary":"Oncopeptides AB ( ($SE:ONCO) ) just unveiled an announcement. Oncopeptides AB, a Stockholm-listed biotech focused on targeted cancer treatments, le...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/oncopeptides-marks-growth-phase-as-2025-annual-report-highlights-pepaxti-momentum?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/oncopeptides-marks-growth-phase-as-2025-annual-report-highlights-pepaxti-momentum?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SG9999005177.SGD","LU1048588211.SGD","IE0001KFT4U8.USD","LU0251143029.SGD","LU0441851309.USD","SG9999002620.SGD","LU0348788117.USD","LU2008162690.USD","LU2177674079.SGD","SG9999002604.SGD","IE0034224299.USD","LU0175139822.USD","BK4581","BK4220","LU0532188223.SGD","BK4085","LU1770036033.HKD","LU0516423091.SGD","LU0979878070.USD","SG9999002414.USD","SG9999013478.USD","LU0516422440.USD","SG9999014492.USD","LU0823039010.USD","LU0572940350.SGD","BK4566","LU2238330802.EUR","IE0031814969.USD","LU2125910849.SGD","LU2065171311.SGD","IE00BD6J9T35.USD","LU2065170008.USD","LU0516423174.USD","LU2360107671.USD","LU0072462343.USD","LU0499858602.USD","LU0589944569.HKD","LU2065169927.USD","LU0572939691.SGD","LU0499858438.USD","BK4588","LU2045819591.USD","ONCO","SG9999004360.SGD","BK4551","SG9999006266.SGD","LU0048573645.USD","LU0289960550.SGD","SG9999014484.SGD","SG9999002406.SGD","LU1242518857.USD","BK4503","BK4585","LU0516422952.EUR","SG9999013486.USD","LU1839390173.USD","LU0264606111.USD","LU2065171402.SGD","LU2152927971.USD","SG9999013460.SGD","LU0737861269.HKD","LU0345775950.USD","LU0516422366.SGD","SG9999002679.SGD","LU0345776255.USD","LU1861217088.USD","LU0823038988.USD","BK4554","SGXZ58947870.SGD","LU1861220207.SGD","BK4548","LU1242518931.SGD","LU2125910500.SGD","SG9999001135.SGD","LU0261945553.USD","BK4535","LU0210637038.USD","LU2543165471.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630332820","title":"BRIEF-Onconetix Inc Andrew Oakley Resigns As Chairman Of Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2630332820","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630332820?lang=en_us&edition=fundamental","pubTime":"2026-04-25 05:01","pubTimestamp":1777064501,"startTime":"0","endTime":"0","summary":"BRIEF-Onconetix Inc Andrew Oakley Resigns As Chairman Of BoardApril 24  - Onconetix Inc ONCO.O:ONCONETIX INC - ANDREW OAKLEY RESIGNS AS CHAIRMAN OF BOARD- SEC FILINGONCONETIX INC - APPOINTS SAMMY DORF AS CHAIRMAN OF THE BOARD EFFECTIVE APRIL 23, 2026 - SEC FILINGSource text: [ID:n0001213900-26-047577]Further company coverage: ONCO.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260424:nFWN4170YL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ONCO"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":71,"code":"91000000","status":"200"}]}}